C4 Therapeutics, Inc. (CCCC) Insider Ownership

Historic Ownership Trends

Based on data from the past 90 days ending December 12, 2025, C4 Therapeutics's three largest insider shareholders are Director Kenneth Carl Anderson (187.89K shares), Chief Medical Officer Leonard Reyno (166.38K shares), Chief Financial Officer Kendra Adams (162.34K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares Report Date
Marc A Cohen 1,875,923 18 Jan, 2022
Alain J Cohen 1,742,858 05 Apr, 2022
Elena Prokupets 503,126 29 Sep, 2021
Andrew Hirsch President & CEO 423,145 18 Feb, 2025
Kenneth Carl Anderson 187,890 03 Oct, 2025
Leonard Reyno Chief Medical Officer 166,382 15 Jul, 2025
Kendra Adams Chief Financial Officer 162,342 19 Sep, 2025
Stewart Fisher Chief Scientific Officer 130,710 17 Sep, 2024
Kelly Schick Chief People Officer 108,885 18 Feb, 2025
Jolie Siegel Chief Legal Officer 107,939 18 Feb, 2025
Scott N Boyle Chief Business Officer 107,805 18 Feb, 2025
Paige Mahaney Chief Scientific Officer 99,356 30 Oct, 2025
Donna Roy Grogan 58,629 03 Oct, 2025
Lauren White Chief Financial Officer 32,686 31 Aug, 2023
Glenn Dubin 22,075 02 Apr, 2024
Adam Crystal Chief Medical Officer 20,097 01 Feb, 2023
Mark Mossler Chief Accounting Officer 18,204 18 Feb, 2025
Malcolm Salter 11,380 18 Jan, 2022
Utpal Koppikar 5,667 10 Feb, 2023

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
28 Oct, 2025 Paige Mahaney Common Stock A 19,200 $0.00 105,000 D M
28 Oct, 2025 Paige Mahaney Common Stock D 5,644 $2.58 99,356 D F
01 Oct, 2025 Donna Roy Grogan Common Stock A 6,740 $2.15 58,629 D A
01 Oct, 2025 Kenneth Carl Anderson Common Stock A 5,349 $2.15 140,574 D A
18 Sep, 2025 Kendra Adams - - 165,117 D
18 Sep, 2025 Kendra Adams Common Stock A 6,250 $0.00 165,117 D M
18 Sep, 2025 Kendra Adams Common Stock D 2,775 $3.32 162,342 D F
18 Sep, 2025 Kendra Adams - - 162,342 D
10 Jul, 2025 Leonard Reyno - - 166,382 D
10 Jul, 2025 Leonard Reyno Common Stock A 15,325 $0.00 173,764 D M
10 Jul, 2025 Leonard Reyno Common Stock D 7,382 $1.99 166,382 D F
10 Jul, 2025 Leonard Reyno - - 166,382 D
10 Jul, 2025 Leonard Reyno Common Stock D 7,382 $1.99 166,382 D F
01 Jul, 2025 Donna Roy Grogan Common Stock A 9,609 $1.51 51,889 D A
01 Jul, 2025 Kenneth Carl Anderson Common Stock A 7,616 $1.51 135,225 D A
01 Apr, 2025 Kenneth Carl Anderson Common Stock A 7,841 $1.44 127,609 D A
01 Apr, 2025 Donna Roy Grogan Common Stock A 9,581 $1.44 42,280 D A
14 Feb, 2025 Paige Mahaney Common Stock A 28,200 $0.00 105,000 D A
14 Feb, 2025 Leonard Reyno Common Stock A 87,100 $0.00 178,909 D A
14 Feb, 2025 Mark Mossler Common Stock D 1,586 $3.18 18,204 D F